CREDIT SUISSE AG/ - ARBUTUS BIOPHARMA CORP ownership

ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 94 filers reported holding ARBUTUS BIOPHARMA CORP in Q1 2021. The put-call ratio across all filers is 2.02 and the average weighting 0.0%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of ARBUTUS BIOPHARMA CORP
ValueSharesWeighting
Q4 2022$2,568
+156.8%
1,102
+78.0%
0.00%
Q3 2022$1,000619
+61800.0%
0.00%
Q2 2022$0
-100.0%
1
-100.0%
0.00%
Q4 2021$44,000
-83.2%
11,271
-87.0%
0.00%
Q2 2021$262,000
-25.1%
86,771
-17.5%
0.00%
Q1 2021$350,000
+414.7%
105,166
+449.1%
0.00%
Q4 2020$68,000
-68.9%
19,151
-91.2%
0.00%
Q1 2020$219,000
-45.7%
216,708
+49.2%
0.00%
Q4 2019$403,000
+379.8%
145,210
+1169.8%
0.00%
Q2 2018$84,000
-92.3%
11,436
-93.5%
0.00%
-100.0%
Q3 2017$1,092,000
+72.2%
176,091
+0.1%
0.00%0.0%
Q2 2017$634,000
+10.8%
176,000
-0.0%
0.00%0.0%
Q1 2017$572,000
+32.7%
176,001
-0.0%
0.00%
Q4 2016$431,000
-29.3%
176,080
-0.7%
0.00%
-100.0%
Q3 2016$610,000
-0.5%
177,260
+0.6%
0.00%0.0%
Q2 2016$613,000
-15.7%
176,270
+0.1%
0.00%0.0%
Q1 2016$727,000
-7.4%
176,150
-0.0%
0.00%0.0%
Q4 2015$785,000
-29.1%
176,231
-3.0%
0.00%0.0%
Q3 2015$1,107,000181,6520.00%
Other shareholders
ARBUTUS BIOPHARMA CORP shareholders Q1 2021
NameSharesValueWeighting ↓
JACOB ASSET MANAGEMENT OF NEW YORK LLC 260,000$866,0000.34%
RTW INVESTMENTS, LP 5,978,355$19,908,0000.31%
GSA CAPITAL PARTNERS LLP 309,839$1,032,0000.17%
QCM Cayman, Ltd. 12,728$42,0000.13%
COWEN AND COMPANY, LLC 486,717$1,621,0000.11%
Hudson Bay Capital Management LP 1,400,000$4,662,0000.06%
Kerrisdale Advisers, LLC 208,150$693,0000.05%
Secure Asset Management, LLC 10,000$33,0000.02%
PDT Partners, LLC 72,500$241,0000.02%
Point72 Asset Management, L.P. 1,037,700$3,456,0000.02%
View complete list of ARBUTUS BIOPHARMA CORP shareholders